Novadip Biosciences
PrivateLast Round
Debt
Dec 14, 2023
Total Funding Raised
$96.54M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Novadip Biosciences is a biotechnology company that develops regenerative tissue products to accelerate healing for large bone defects, bone non-union, and spine fusion.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novadip Biosciences Comparables
Compare Novadip Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpiBone | 84% | |
| Bonus Biogroup | 81% | |
| Theradaptive | 73% | |
Novadip Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 14, 2023 | ||||
| Series B Extension | Nov 3, 2022 | ||||
| Series B | Oct 28, 2021 | ||||
| Series A | Sep 10, 2015 |
Key People
Founding team and executive leadership
Novadip Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| Sopartec | Series B, Series A, Series B Extension |
| Epimede | Series A |
| Fund+ | Series A, Series B, Series B Extension |
| Société Régionale d'Investissement de Wallonie | Series A |
| Investsud | Series B, Series B Extension |
| European Investment Bank Group | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 69% MoM, reaching 3.6K.
- Jun 18, 2026
Monthly visitors increased 418% MoM.
Novadip Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novadip Biosciences's valuation, stock price, and market status.